Stocks To Buy Now Blog

All posts by Christopher

eXp World Holdings, Inc. (EXPI) Still Growing Despite the 2016 Drop in Housing Affordability

At the end of 2016, the Federal Reserve announced that it would be raising its key interest rate for the first time since the housing bubble burst between 2005 and 2006. According to an article on Realtor.com (http://dtn.fm/M08dy), the interest on a 30-year fixed rate mortgage is expected to grow from under 4.2% in 2016 to anywhere between 4.5% and 5% by the end of this year.

Despite the rise in home prices slowing, they are still expected to go up 4% in 2017. In addition, Realtor.com (http://dtn.fm/SaW2o) reported 12% less available homes for sale in November 2016 than in the previous year. Despite a shortage of homes on the market, the U.S. Commerce Department’s new residential sales report (http://dtn.fm/eC1Ww) stated that permits to put up new residences fell in November 2016. This was accompanied by fewer home constructions during the month, down nearly 20% below the revised October 2016 estimates. With the rise in mortgages and home prices, coupled with the low inventory of houses on the market today, buyers are expected to struggle to find their perfect homes.

Although the end of 2016 showed cause for concern for real estate businesses across the country, inventory for January moved at a 4% faster annual rate (http://dtn.fm/IhtZ6). This stronger than usual off-season has left a low volume of available homes for sale with very high prices. But this dip in volume has not halted the rising interest in eXp World Holdings, Inc. (OTCQB: EXPI), holding company of eXp Realty LLC, or its growth.

The agent-owned, cloud-based real estate brokerage has continued to see a significant rise in new agents and brokers, with a growth rate of over 100% thanks to its technology revenue sharing and ownership. The company has accepted over 100 new agents and brokers into its team in the month of February alone, leading to more virtual meetings with a significant growth in attendance.

The company’s stock price has been powering higher for the best part of two years, reaching $3.96 per share in afternoon trading on Tuesday. EXPI recently announced the addition of its newest team member, real estate veteran and former quarterback for the Los Angeles Rams Vince Ferragamo.

For more information, visit the company’s website at www.eXpWorldHoldings.com

Let us hear your thoughts: eXp World Holdings, Inc. Message Board

Singlepoint, Inc. (SING) CEO Greg Lambrecht Discusses Acquisition Targets on Money TV with Donald Baillargeon

On a recent episode of Money TV with Donald Baillargeon (http://dtn.fm/6Fu9t), an internationally syndicated television program focusing on financial and economic issues, Singlepoint, Inc. (OTC: SING) chief executive officer, founder, and President Greg Lambrecht discussed his company’s exponential growth and its immediate acquisition plans as the driving force behind the recent increase in stock volume and price. Lambrecht and Baillargeon started the interview by noting how appropriate the company’s ticker symbol is, given that the company has indeed been “singing” lately on the stock market. Singlepoint has been one of the highest volume OTC companies for the last two weeks, Lambrecht said.

The Singlepoint CEO underlined that his company’s main strategy is based on strategic acquisitions that can help it expand its portfolio and get its revenues up. A leading provider of mobile technology, mobile marketing and mobile payment services, Singlepoint already has acquisitions in several verticals, including fantasy sports, mobile payment and auction software, digital advertising and more. Its most recent focus, however, has been the ever-growing cannabis industry. In the wake of last year’s election that made medical and/or recreational marijuana use legal in eight more states, bringing the total number of states that allow the substance to 28, Singlepoint reactivated its SingleSeed Payments subsidiary – a merchant payment processing company aiming to serve legal marijuana businesses. The company also announced plans to expand its reach on the market through new acquisitions.

“We put up an LOI a couple of weeks ago, and you’re going to hear about that soon,” Lambrecht said during the interview. “We also have two other LOIs out there so we are really focusing on acquisitions, and Singlepoint is going to be presenting some very big and very good news on those acquisitions in the near future.”

The Singlepoint CEO did not go into more detail about what acquisitions his company is planning, but he did speak more extensively about the main criteria for these acquisitions. “One of the main criteria right now is that they are in the cannabis business and particularly that they’re in the cannabis business but they don’t actually touch the cannabis – just like us, a merchant processor in the dispensaries,” he explained. One of the companies that meets this criterion and that Singlepoint is already targeting for acquisition is Convectium, which manufactures a unique and innovative oil filling machine able to fill cartridges and disposable vape pens for dispensaries or wholesale distribution. Besides Convectium, Singlepoint is also discussing acquisition with a company that is on the software side of the cannabis industry, Lambrecht said.

In addition to this criterion, another major factor that can decide an acquisition is, naturally, the target company’s financials. “The other companies that we’re looking at have really strong EBITDA and strong revenue numbers,” the Singlepoint CEO said.

Lambrecht also discussed his company’s joint ventures, including venture plans with a couple of mobile pay companies that are expected to be revealed soon and could bring considerable revenue to Singlepoint. The company’s massive success on the market in terms of stock price and volume has also drawn the interest of institutional investors. “We’re getting a lot of attention from Wall Street and other that, even though we’re a Pink and right now we’re offering rule 144, that doesn’t seem to bother them. With our volume and stock price, we have a lot of interested parties that want to invest in Singlepoint and I get why: they know that through the next year, with our acquisitions and joint ventures that we have planned, hopefully the stock in 12 months (…) is going to be the same volume and certainly higher price,” Lambrecht explained.

Furthermore, he said that all the money raised from these investments is going directly toward acquiring companies. “That’s where it should go and that’s where it’s going and this is just going to make the company stronger and have a higher market cap.”

For more information, visit the company’s website at www.Singlepoint.com

Let us hear your thoughts: Singlepoint, Inc. Message Board

Monaker Group, Inc. (MKGI) Offers Business and Leisure Travelers Specialized Travel Tools with Maupintour

Maupintour (www.maupintour.com), a specialized tour operator owned by Monaker Group, Inc. (OTCQB: MKGI), is a hidden gem for both Monaker and its users. Maupintour, founded by Tom Maupin, designs comprehensive and creative tours for groups and individuals, offering travelers the opportunity to arrange uniquely customized tours to exotic locales. Other travel companies have booking engines that can arrange business travel, but Monaker has the unique advantage of owning a subsidiary, Maupintour, which designs specialized tours for the business traveler seeking to turn a business trip into a customized leisure adventure.

According to a 2016 Global Business Travel Association Index study (http://dtn.fm/iZ8rA), 45% of business travelers at firms with 1-249 employees extend their trips to combine business and leisure travel. Especially for younger travelers, extending company paid travel with additional days of personal travel offers them the chance to explore destinations they have already reached. Monaker’s booking engine is perfect for them to integrate the booking of business and leisure travel using the company’s efficient NextTrip.com site. For Monaker, Maupintour represents an important additional revenue stream.

To high-tech travelers, Monaker Group’s Maupintour is something very special. This 65-year-old tour arm of the company specializes in tailored tours to travelers who are adventurous and curious to try exotic trips. A business trip to Athens, Greece, can become a Maupintour archeology tour. A business meeting in Rome can become a specialized tour of the Vatican. A meeting in Chile can be extended and turned into a customized wine-tasting tour. A ho-hum business trip to a foreign location can become, by extension, an economical but glorious leisure trip, as well.

The Index study found that these travelers would use leisure travel not only to explore these destinations, but also to visit family and friends. In addition, it found that learning about a destination’s cultural offerings was important to these employees.

Monaker Group is a technology-focused company that is travel-driven, targeting the alternative lodging market (ALM). Bill Kerby, founder, chairman, and CEO of Monaker, sees ALR as one of the fastest expanding sectors of the entire travel market, projected by industry experts to reach $169 billion by 2019.

The company’s real-time booking engine offers ALR inventory, plus access to air, conventional lodging, business travel needs, and a library of greater than 15,000 video clips of destinations and leisure activities, cruises, and other travel, all on one site.

For more information, visit www.MonakerGroup.com

Annual Market Review Reveals OTC Markets Have Come of Age

After a century of service providing quotes on stocks and bonds to investors around the world, the OTC markets have come of age, and the recently published Annual Markets Review (http://dtn.fm/IW0iC) from OTC Markets Group, Inc. (OTCQX: OTCM) reveals that maturity. The company’s over-the-counter (OTC) platforms now host some 9,620 U.S. and global securities that generate an annual trading dollar volume of around $193 billion. Its OTCQX Best Market and OTCQB Venture Market provide price and liquidity information on some of the world’s best companies, and over 100 broker-dealers play an active part as market-makers. For companies, both big and small, being quoted on the OTC markets makes being public decidedly less painful.

The current tiered market structure makes it easier for companies to demonstrate their financial and corporate governance standards and to provide current information, avoiding the trading hurdles due to the opacity associated with the old pink sheets. The almost 10,000 securities included in the OTC Markets quotation system are organized into three markets, OTCQX, OTCQB, and Pink, to better inform investors.

The OTCQX Best Market is the premier quotation platform. To be quoted on the OTCQX market, a company must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, and have a professional third-party sponsor introduction. Penny stocks, shell companies and companies in bankruptcy cannot qualify for OTCQX. The companies whose securities appear on the OTCQX are distinguished by the integrity of their operations and the diligence with which they convey their qualifications. The OTCQX Best Market, which welcomed some 50 new companies in 2016, offers transparent and efficient trading… without the cost and complexity of a U.S. exchange listing.

The OTCQB Venture Market is meant for early-stage and developing U.S. and international companies that are not yet able to qualify for OTCQX. To be eligible, a company must be current in its reporting and undergo an annual verification and management certification process. It must, also, meet a $0.01 bid test and may not be in bankruptcy. In 2016, 230 new companies joined the platform.

The Pink Open Market approximates most closely to the traditional pink sheets, although a particular market tier classification is not an indication of either the value of the security or an endorsement (or not) of the issuer. Market tiers are based only on the quality and timeliness of the information provided. OTCQB Venture Market and Pink Open Market quotes may be of securities for companies of high quality, as well as of those for speculative, distressed, or questionable companies.

Since May 16, 2013, the U.S. Securities and Exchange Commission (SEC) has considered the OTCQB and OTCQX marketplaces to be public marketplaces for purposes of establishing a public market price when registering securities for resale in equity line financings.

During 2016, the OTC Markets Group platforms passed some memorable milestones. Some 280 new companies made their debut on the OTCQX and OTCQB markets. In particular, the OTCQX shone under the spotlight: the OTCQX Best 50 companies (http://dtn.fm/0XznV) delivered an average total return of 130 percent compared to the S&P 500, which went up by 9.5 percent in 2016.

Twenty U.S. states now recognize the OTC markets for the purposes of their Blue Sky Manual Exemptions. Blue Sky laws are U.S. state securities laws designed to protect the public from securities fraud. The aim is to achieve Blue Sky recognition from all 50 states. In addition, seven share transfer agents participate in a new program that makes current verified information available to the public.

Client companies are voicing their approval of the measures to improve the OTC markets. As global information services giant Experian plc explained:

“…OTCQX offered a liquid trading platform for our ADRs, enabling US investors to invest directly in Experian stock via a US traded instrument, but it did not require us to list on a US exchange or register with the SEC. As a result, we continue to comply with the regulation and governance requirements of our primary London listing and are not subject to onerous duplicate regulation and governance requirements by virtue of our ADRs being traded in the US.”

It looks like the OTC Markets have definitely come of age by making being public much less painful.

For more information, please visit www.OTCMarkets.com

Net Element, Inc. (NASDAQ: NETE) Offering Businesses State of the Art Payment Solutions

We live in a technologically advanced world where consumers are able to purchase virtually anything, at any time, using online as well as offline stores and services. From finding an item to buying it and getting it delivered straight to their doorstep, purchasing is increasingly done with just the click of a few buttons. The average 21st-century shopper expects to be able to pay for his or her products quickly and easily, whether online or offline.

According to a report by Grand View Research on the point-of-sale market (http://nnw.fm/N6Yea), the global point-of-sale terminals market is expected to reach over $113 billion by the end of 2024. This has been largely put down to the introduction of higher security measures, which has minimized user concerns, along with the evolution of wireless internet, Bluetooth devices, card readers, mobile printers, and many other technologies.

With generations Y and Z showing an increased understanding of technology, users are not only seeking new ways to make their payment process easier, but also quicker. As a result, tech and payment solution companies are creating systems whereby consumers can pay via mobile, contactless, and various other innovative mediums.

Omnichannel payment processing businesses are on the rise, offering customers payment options across a range of sales channels and devices. Net Element, Inc. (NASDAQ: NETE), a technology-driven company specializing in mobile payments and value-added transactional services, offers these options by using powerful tools that take into account the latest in technological innovation and security.

Most recently, the company announced that it will be presenting its new point-of-sale program during its 2017 launch, starting with the annual Northeast Acquirers Association conference (NEAA). The presentation is said to include topics relating to NETE’s point-of-sale solutions, including associated mobile solutions; its Poynt, Unified mPOS, Aptito, and gift card programs; its partnering opportunities; and its try-before-you-buy program.

Net Element, Inc. covers a wide range of omnichannel payment solutions in the United States and Central and Southwestern Asia, and it has established a variety of partnerships across the world, including those with Amex and MasterCard. The company now allows businesses on an international level to accept payments over the phone, on mobile, online, and through point-of-sale terminals.

For more information, visit www.NetElement.com

IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) Abuse Deterrent Technology featured at Healthcare Conference

The ‘2017 Disruptive Growth & Healthcare Conference’, which ran February 15-16 at the Convene at 730 Third Avenue Conference Center in midtown Manhattan, New York, featured some stellar participants, either as presenters or as sponsors. Along with over 60 other firms in a variety of fields related to biotech, IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) (TSX: I) was on the bill. The Toronto, Ontario-based company was scheduled to introduce its drug delivery technologies and exhibit its leading pipeline candidates.

The ‘2017 Disruptive Growth & Healthcare Conference’ hosted by RHK Capital, which formerly operated as Source Capital Group, was sponsored by leading investor relations and financial services firms, including NetworkNewsWire, a Platinum Sponsor.

With its drug delivery technologies built on the Hypermatrix™ platform, IPCI is targeting billion dollar markets. The company’s extended release (ER) (XR) formulations provide mechanisms to slowly dissolve and release constant amounts of a medication over time. Instead, of a patient having to take a pill three times a day, with the risk of losing count or forgetting, one daily dose will improve efficacy. Closer compliance with prescription rules results in better therapy.

ER formulations, widespread for leading indications, are expanding to new drugs. Medications that benefit from the IPCI technology include Oxycodone XR, Dexmethylphenidate ER, Venlafaxine ER, Desvenlafaxine ER, Levetiracetam ER, Lamotrigine ER and Pregabalin. Together, these pharmaceuticals present a market opportunity that exceeds $9 billion.

But a bigger prize is the market for abuse deterrent formulations (ADF), which attempt to fight prescription drug abuse by increasing the difficulty of inappropriate use of opioid medications. In the U.S., opioid abuse is on the rise. Data published by the American Society of Addiction Medicine reveals that in 2015 there were 21,101 deaths caused by opioid overdose. Opioids include licit substances such as codeine, fentanyl, hydrocodone and oxycodone, and illicit ones such as heroin and opium. This is a market estimated to be about $60 billion.

Apart from having its eye on these two lucrative opportunities, IPCI has a growing pipeline of new candidates that may lead to New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) filings. An NDA is filed when a sponsor believes there is enough evidence on a new drug’s safety and effectiveness to support FDA approval to bring it to market. An ANDA is required for generic drugs that are bioequivalent to a drug already being marketed.

IPCI has two novel NDA candidates, Rexista® and Regabatin XR™. Earlier this month, the company announced it had filed a New Drug Application (NDA) seeking authorization to market its Rexista™ abuse-deterrent oxycodone hydrochloride extended release tablets in the 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg strengths.

The FDA has determined that the company’s application is sufficiently complete to permit a substantive review, and has set a target action date under the Prescription Drug User Fee Act (PDUFA) of September 25, 2017. IPCI was able to demonstrate that Rexista™ is bioequivalent to OxyContin® (oxycodone hydrochloride extended release). With this upcoming milestone, IPCI will be setting another marker on its journey to success.

Founded in 1998 by the husband and wife team of Dr. Isa Odidi and Dr. Amina Odidi, IPCI has come a long way. The company now specializes in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals.

Based on this technology platform, Intellipharmaceutics has developed several drug delivery systems and a pipeline of products in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.

For more information, visit www.Intellipharmaceutics.com

The Diversification of Auxilio, Inc. (AUXO)

Auxilio, Inc. (NYST MKT: AUXO) is one of a select number of businesses headquartered in Mission Viejo, a mainly residential city in Orange County, California, and a closer look at this small yet booming business shows that it is unique not only for where its offices are based, but also for its value proposition.

Auxilio offers managed print services exclusively to the U.S. health care industry. A leader in this sector due to its innovative and customer-driven approach, Auxilio takes full responsibility for its health care clients’ on-site print environment through situation assessment, process analysis, strategy development and program implementation. The company also works closely with hospitals and hospital systems to deliver quality patient care and accomplishes this objective by providing a customized, scalable document solutions strategy that analyzes, remediates and manages document and print workflows from start to finish.

A vendor-independent company, Auxilio provides intelligent solutions, a risk-free program and guaranteed savings. It assumes all costs related to the print business environment by customizing, streamlining and seamlessly integrating its services at predictable fixed rates that are unmatched in the industry. As a result, its print management programs drive out costs, increase employee productivity and exceed patient care standards, and the hospitals and health systems that work with the company benefit from its streamlined and aligned processes and infrastructure.

For over 10 years, more than 200 of the leading hospitals and health systems in the U.S. have turned to Auxilio to resolve their broken document and digital workflow processes, and its document solutions have helped them reduce waste, safeguard protected health information (PHI) and improve operational efficiency while driving incredible cost savings. The company consistently delivers for its clients by leveraging its three core services lines: Managed Print Services, Document Consulting and iPLATFORM, an intelligent workflow automation suite.

According to the Orange County Business Journal’s 2016 Special Report (http://dtn.fm/C0x5k), from 2014 to 2016, Auxilio clocked more than 40% in growth, making it one of the fastest-growing public companies in the Orange County area. During this time, the company grew its existing business by continuously delivering excellent customer service, and it diversified into cyber security by acquiring two information technology security firms. The resulting demand for Auxilio’s cyber security services and rapid adoption of its Managed Print Services program by many large health care institutions contributed significantly to its recent swift growth.

For more information, visit www.AuxilioInc.com

New Age Beverages Corp. (NASDAQ: NBEV) Announces NASDAQ Capital Market Listing

Colorado-based New Age Beverages Corp. (NASDAQ: NBEV) has priced an underwritten public offering valued at approximately $15 million in gross proceeds and listing on the NASDAQ Capital Market, per a recent press release (http://dtn.fm/E8gLm). The corporation has also granted underwriters an additional opportunity to purchase 642,857 more shares of common stock. This 45-day option will enable them to purchase the extra shares to cover over-allotments. The total gross proceed amount is an estimate before underwriting discounts, commissions, and other offering expenses are deducted.

The company has already filed a registration statement with the Securities and Exchange Commission (SEC). Effective as of February 13, 2017, the filing relates to the securities now being offered. Acting as joint book-running managers are Aegis Capital Corp. and Maxim Group LLC. The recently issued offering will be made only by prospectus, a legal document that must be filed with the SEC, which is available by contacting New Age Beverages Corp. or by visiting the SEC website.

Founded in 2003, New Age Beverages Corp. markets several famous brands of beverages, such as XingTea®, Búcha® Live Kombucha, and Aspen Pure® Rocky Mountain Water. Marley Mellow Mood® Relaxation Drinks and Marley One Drop® Coffee are other products marketed by the company, following the signing of a management agreement in October 2016. The company is now competing in the health and functional beverage segment, a fast-growing area of the beverage market, and sells its brands in all 50 U.S. states. Its brands are also sold internationally, in over 10 countries, across all channels. Some have even gained notoriety. XingTea® recently beat over 250 competitors to earn the title of the ‘#1 Best Tasting Tea’ at the North American Tea Championship.

One of the largest independent distributors in the country, New Age Beverages Corp. reaches over 20,000 outlets from its distribution network in Colorado. It distributes over 60 different brands, representing over 600 SKUs of non-alcoholic and alcoholic beverages, snacks and specialty products. These include the all-natural, non-GMO Xing Energy drink. The employee-owned company recently merged with Marley Beverage Company, which was created in partnership with Bob Marley’s family and is a business that has become reputable in its own right. New Age Beverages Corp. is led by Chief Executive Officer Brent Willis. He has over 20 years of General Management, C-Level, and Board experience and has worked with the Coca-Cola Company (NYSE: KO), Kraft Heinz Company (NASDAQ: KHC), and other global leaders. The company has leveraged an organizational structure focused on testing product innovations, finding emerging products and segments early, and gaining credibility with national distributors.

New Age Beverages Corp. also distributes leading brands such as Nestea®, Nestle Nesquik®, Welch’s, and V8®, among a wide range of others. It understands the value of choosing healthy products. Focused on thinking big, changing the world, teamwork, and execution, the company delivers products that taste good and are affordable for retailers and consumers.

To find out more information, visit www.NewAgeBev.us

Singing Machine Company, Inc. (SMDM) Reports 9% Sales Growth for Nine Months, Debuts a Line for Kids

The Singing Machine Company, Inc. (OTCQX: SMDM) recorded revenue growth of 9% to $49.3 million for the nine months ended December 31, 2016, compared to $45.2 million for the comparable period in 2015 (http://dtn.fm/j9NfF). For the quarter ended December 31, 2016, sales dropped to $16.3 million compared to $20.7 million during the same period of the prior year. The company said that drop was due to the timing of shipments, which occurred earlier in 2016 than the prior year.

Singing Machine makes a line of karaoke products, offering the consumer access to some 1,300 songs. The music can either be downloaded or streamed. The Singing Machine home line is available in North America or internationally through mass merchant and online retailers. The company is also entering the toy business with Singing Machine Kids (http://dtn.fm/QyN7U), a range of 11 new products for children from preschool through elementary school. The line of sing-a-long products is being shown for the first time to buyers at the New York Toy Fair, February 18-21, 2017.

The company’s net income jumped 3.9% for the nine months ended December 31, 2016, to $2,685,561, up from $2,583,460 for the nine months ended December 31, 2015. For the three months ended December 31, 2016, sales dropped 21% to $16,319,804 compared to $20,667,069 for the comparable period the prior year. Similarly, net income dropped 35% to $1,312,158 for the three months ended December 31, 2016, from $2,006,913 during the same three-month period of the prior year.

Gary Atkinson, Singing Machine CEO, said, “This fiscal year we’ve grown net sales by 9% over last year and we’ve grown pre-tax net income by 33% to $4 million. On the product roadmap, we significantly expanded our distribution of our Digital Download Line of products and saw impressive growth in both downloading and streaming subscriptions.”

Bernardo Melo, VP of Sales, commented that ecommerce has grown to more than 18% of company sales. He said the company enjoyed an average 88% sell-thru across major retailers on both Black Friday and the Christmas season.

The company is unveiling its Singing Machine Kids line and will also, through its partnership with Stingray, offer a karaoke Sing-Along mobile app to be available in the fall. The app, available for both iOS and Android devices, will complement the Singing Machine Kids line.

The toy product line consists of 11 items, including:

  • Bluetooth Recording Studio, a portable studio with six sound effects loaded in advance.
  • Mic Guy Bluetooth Sing-Along, a battery operated system designed for the littlest singers.
  • Candy House Sing-Along, a joyful speaker system with a colored lit roof top.
  • Blackboard Calculator, designed to make math interactive and fun with the Wise Old Owl.

“We’re incredibly proud of our new kids line,” commented CEO Atkinson. “Not only have we designed a range of products that will enhance our mission of spreading joy through music, we have also created products that will help kids with a variety of early learning and developmental skills.”

For more information, visit www.SingingMachine.com

ORhub, Inc. (ORHB) Aims to Cut Annual US Health Care Spending by $250 Billion

ORhub, Inc. (OTC: ORHB), is a cloud-based health care software-as-a-service company whose primary aim is to improve the outcome and reduce costs of surgical care in a variety of hospitals and health care institutions in the United States.

Because many hospitals still rely on paper documentation to track everything that occurs during an operation, there is more space for mistakes, missing information, delays, and payment problems, as well as, generally, less opportunity to effectively improve procedures. ORhub’s digital platform eliminates a variety of the limitations and problems inherent with paper documentation.

Aside from reducing potential mistakes, the platform creates automatic records, streamlines tasks to save time, and enables rich data analysis across all of the hospital’s cases. This allows health care institutions to more easily determine whether comparable surgeries cost the same, the types of implants needed and how they are used, and any inventory that needs to be restocked.

In recent news, the company went through a merger (http://dtn.fm/3bllA) between MemReg, Inc. and ORhub, Inc., with MemReg formally changing its name and ticker symbol to align with its new identity. It’s part of a process to put together initiatives for improving liquidity, strengthening brand recognition, and preparing for future listing on a senior exchange.

Most recently, the company expanded its pilot program (http://dtn.fm/kO4H7) to include one of the top five highest-volume orthopedic hospitals in America. This hospital has been given a five-star rating by the U.S. Centers for Medicare and Medicaid and has been ranked as one of the best orthopedic hospitals in the country two years in a row by U.S. News & World Report. In addition, it is the highest volume provider of joint replacements in California, according to California’s Office of Statewide Health Planning and Development (OSHPD), and is one of only eight hospitals in the state to be classified as a “Highest-Rate Hospital” for knee and hip surgery in 2016 by Consumer Reports.

In a news release, Chief Technology Officer Wesley Mitchell commented, “Our goal is to cut $250 billion out of annual U.S. health care spending by reducing cost and increasing efficiency in surgical operations, which is roughly one-third of the $3 trillion spent on health care in the U.S. every year. Moving forward with one of the most efficient hospitals in the nation gives us a platform to show that what we are doing can have a significant impact at any hospital, even one already praised for its efficiency.”

For more information, visit the company’s website at www.ORhub.com

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

May 13, 2025

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies […]

Rotate your device 90° to view site.